Latest Articles
Ascentage Pharma Presents Promising Cancer Research at AACR - The Clinical Trial Vanguard
Ascentage Pharma Presents Promising Cancer Research at AACR The Clinical Trial Vanguard
Published: April 20, 2026, 8 a.m.
'I'm a gynaecologist and there's hidden ovarian cancer symptom you must never ignore' - The Mirror
'I'm a gynaecologist and there's hidden ovarian cancer symptom you must never ignore' The Mirror
Published: April 19, 2026, 6 a.m.
Gynaecologist shares little-known ovarian cancer symptom every woman should know - Wales Online
Gynaecologist shares little-known ovarian cancer symptom every woman should know Wales Online
Published: April 19, 2026, 6 a.m.
BioNTech’s BNT323 Achieves Strong Phase 2 Response Rates in Endometrial Cancer - Oncodaily
BioNTech’s BNT323 Achieves Strong Phase 2 Response Rates in Endometrial Cancer Oncodaily
Published: April 18, 2026, 6:23 p.m.
Impact of Overall Survival Data on Immunotherapy Selection in Endometrial Cancer - Pharmacy Times
Impact of Overall Survival Data on Immunotherapy Selection in Endometrial Cancer Pharmacy Times
Published: April 17, 2026, 12:30 p.m.
Navigating the Clinical and Economic Burden of Endometrial Cancer - Pharmacy Times
Navigating the Clinical and Economic Burden of Endometrial Cancer Pharmacy Times
Published: April 17, 2026, 12:30 p.m.
A Chemo-Free Option for Some Advanced Endometrial Cancers? - Medscape
A Chemo-Free Option for Some Advanced Endometrial Cancers? Medscape
Published: April 17, 2026, 11:26 a.m.
Doctor Calls Bispecific Results “Phenomenal” in Advanced Endometrial Cancer Trial - CU Anschutz newsroom
Doctor Calls Bispecific Results “Phenomenal” in Advanced Endometrial Cancer Trial CU Anschutz newsroom
Published: April 16, 2026, 11:26 p.m.
Utah Volleyball Community Raises Funds for Former Athlete Battling Cancer - world.infonasional.com
Utah Volleyball Community Raises Funds for Former Athlete Battling Cancer world.infonasional.com
Published: April 16, 2026, 10:37 p.m.
High Response Rates in Platinum-Resistant Ovarian Cancer With Immunotherapy Agents - MedPage Today
High Response Rates in Platinum-Resistant Ovarian Cancer With Immunotherapy Agents MedPage Today
Published: April 16, 2026, 7:11 p.m.
Link copied to clipboard!